The Southeast Asia veterinary nutraceuticals market was valued at USD 1.85 billion in 2026. This market is expected to reach USD 3.38 billion by 2036, growing at a CAGR of 6.2% from 2026 to 2036.

Key Market Highlights

• Thailand accounts for around 20–25% of the Southeast Asia veterinary nutraceuticals market in 2026, driven by a mature pet food manufacturing sector and strong veterinary infrastructure.
• Indonesia and Vietnam are projected to be the fastest-growing markets through 2036, propelled by rapid urbanization and expanding commercial livestock production.
• Companion Animals represent the largest animal type segment, accounting for the majority of veterinary nutraceutical demand in 2026.
• Dogs maintain the largest share within the companion animal segment due to higher healthcare spending and widespread supplement utilization.
• The Philippines and Thailand exhibit exceptionally high dog ownership rates, supporting robust demand for companion animal nutraceuticals.
• Joint Health Supplements segment is the largest product category by revenue across the region.
• Glucosamine, chondroitin, MSM, and omega-3 products remain the most extensively utilized joint health ingredients for aging pets.
• Digestive Health Supplements are the fastest-growing product segment in Southeast Asia.
• Probiotics and prebiotics are increasingly deployed to support gut health, immunity, and feed efficiency in both pets and livestock.
• Preventive Care & General Wellness account for the largest application segment in 2026.
• Restrictions on antibiotic growth promoters are accelerating nutraceutical adoption in regional livestock production.
• Poultry and aquaculture represent critical livestock markets for probiotics and immune-support products in Southeast Asia.
• E-commerce platforms are emerging as the fastest-growing distribution channel, enhancing access to specialized nutraceuticals.
• Regional companies like Betagro Group and Biotechpharma are actively investing in condition-specific and species-specific formulations.
• Companion animal products generate higher profit margins than livestock nutraceutical products.

Veterinary Nutraceuticals Market Overview

The veterinary nutraceuticals market  across Southeast Asia is an essential pillar of modern animal healthcare and nutrition. Historically, animal health management in the region depended almost entirely on pharmaceuticals and therapeutic interventions to treat diseases after they emerged. However, growing awareness regarding preventive healthcare, increasing concerns over antimicrobial resistance in agriculture, and the rapid humanization of companion animals have altered animal health management paradigms. Today, nutraceuticals are increasingly integrated into preventive care programs, chronic disease management protocols, and livestock nutrition systems to ensure long-term health, optimize productivity, and enhance animal welfare across the ASEAN region.

The increasing use of veterinary nutraceuticals is primarily driven by the rapid expansion of the regional pet population and increasing per-capita spending on animal healthcare. Emerging markets, including Thailand, Indonesia, Vietnam, and the Philippines, are experiencing 7–10% annual growth in pet ownership. The Philippines now boasts one of the highest dog ownership rates globally at 67%, while Thailand leads the Asia-Pacific region in cat ownership at 47%. As disposable incomes rise across urban centers in Southeast Asia, the willingness of pet owners to invest in premium healthcare and wellness products has surged. As companion animals increasingly assume the role of family members, demand for joint health supplements, probiotics, omega-3 fatty acids, cognitive support products, and condition-specific nutritional solutions continues to accelerate.

The commercial livestock sector also serves as a key catalyst for nutraceutical adoption in the region. Southeast Asia is a global hub for poultry, swine, and aquaculture production. Vietnam's hog and poultry production is expanding rapidly, projected to reach 33 million metric tonnes by 2028, while Indonesia remains the largest beef producer in the region. Concurrently, regulatory authorities across ASEAN nations are implementing stricter guidelines on the routine use of antibiotics in food-producing animals. These antimicrobial stewardship initiatives have accelerated the transition toward probiotics, prebiotics, phytogenics, yeast derivatives, organic acids, and immune-support nutraceuticals as viable, scientifically validated alternatives for maintaining animal health and optimizing production yields.

The growing research into the animal microbiome has illuminated the vital role of gut health in immunity, nutrient absorption, growth performance, and disease resistance. Consequently, probiotic and digestive health products have emerged as the fastest-growing veterinary nutraceutical categories in the region. The high-density farming practices prevalent in Southeast Asian poultry and aquaculture operations necessitate robust microbiome support. Similarly, osteoarthritis remains a prevalent chronic condition in aging companion animals across the region, driving strong demand for glucosamine, chondroitin, collagen, and omega-3-based joint health supplements.

The SEA pet nutraceuticals market is further driven by substantial investments from both global animal health conglomerates (e.g., Zoetis, Boehringer Ingelheim, Elanco) and regional nutrition companies. Major players are broadening their portfolios of functional supplements, condition-specific nutraceuticals, and precision nutrition products tailored for companion animals, poultry, swine, ruminants, and aquaculture species. Innovations in formulation technologies, palatability enhancement, microencapsulation, and bioavailability optimization are elevating product efficacy and consumer acceptance. As veterinary care in Southeast Asia increasingly pivots toward prevention, wellness, and proactive health management, nutraceuticals are poised to become an indispensable component of animal healthcare systems throughout the region.

Segment Analysis

By Animal Type

Companion Animals

Companion animals command the largest share of the overall Southeast Asia veterinary nutraceuticals market, with dogs accounting for the vast majority of segment revenue. This dominance is propelled by surging pet ownership, escalating pet healthcare expenditure, the profound humanization of pets, and expanding demand for preventive wellness products across the region.

Southeast Asia exhibits remarkable pet ownership statistics. The Philippines records the highest dog ownership rate at 67%, while Thailand follows closely at 47%. Furthermore, Thailand holds the top position in cat ownership across the broader Asia-Pacific region at 47%. Dogs typically generate substantially higher veterinary spending than most other companion animals due to greater utilization of healthcare, wellness, and nutritional products.

Age-related health conditions serve as a primary catalyst for supplement demand. Veterinary studies indicate that 60–70% of senior dogs are affected by osteoarthritis, sustaining robust demand for glucosamine, chondroitin, collagen, and omega-3 supplements. Similarly, gastrointestinal disorders, obesity, cognitive decline, and dermatological conditions are amplifying the demand for probiotics, digestive enzymes, antioxidants, and cognitive-support nutraceuticals. As pet owners increasingly prioritize quality of life and healthy aging, companion animals are projected to remain the largest revenue-generating segment throughout the forecast period.

Livestock Animals

Livestock animals are the fastest-growing segment of the Southeast Asia veterinary nutraceuticals market, driven by the growing demand for antibiotic alternatives, the imperative to improve animal productivity, and the adoption of sustainable livestock production practices. Poultry and aquaculture account for a substantial share of demand due to the scale and intensity of commercial production systems in the region.

Southeast Asia is a powerhouse in global animal production. Vietnam's hog and poultry production is expanding at an unprecedented rate (projected to reach 33 million metric tonnes by 2028), while Indonesia stands as the largest beef producer in the region. The immense scale of animal nutrition markets means that even marginal improvements in feed efficiency, disease resistance, or animal performance can generate substantial economic benefits for producers.

The segment is capitalizing on the increasing adoption of probiotics, prebiotics, phytogenics, yeast derivatives, organic acids, and immune-support products as producers endeavor to optimize gut health and diminish reliance on antibiotics. Research demonstrates that feed additives supporting microbiome health can enhance feed conversion ratios, growth performance, and disease resilience in poultry, swine, ruminants, and aquaculture species. As regional demand for meat, milk, eggs, and seafood continues its upward trajectory, livestock producers are anticipated to remain major adopters of veterinary nutraceutical products.

By Product Type

Joint Health Supplements

Joint Health Supplements is the largest product category within the Southeast Asia veterinary nutraceuticals market. The substantial share of this segment is primarily driven by the high prevalence of musculoskeletal disorders in companion animals, particularly aging dogs and large breeds. As pet lifespans continue to extend due to better overall care, mobility-related conditions are emerging as a major focus of preventive veterinary medicine.

Conditions such as osteoarthritis and hip dysplasia often necessitate long-term management, underpinning sustained demand for joint health products. Glucosamine, chondroitin sulfate, MSM, collagen peptides, hyaluronic acid, and omega-3 fatty acids remain among the most extensively utilized ingredients in veterinary joint supplements. The combination of high disease prevalence, lifelong supplementation requirements, and strong veterinary recommendation rates ensures that joint health remains the largest revenue-generating product segment.

Digestive Health Supplements

Digestive Health Supplements are projected to register the fastest growth during the forecast period. The rapid expansion of this market is primarily attributed to the advancing scientific comprehension of the animal microbiome and its critical role in digestion, immunity, nutrient utilization, and comprehensive health.

Gastrointestinal disorders account for a significant portion of veterinary consultations in companion animals, while digestive diseases remain among the most prevalent causes of productivity losses in poultry and swine production. This reality has increased demand for probiotics, prebiotics, postbiotics, digestive enzymes, yeast derivatives, and gut-health formulations across both companion animal and livestock sectors.

Following increasing restrictions on antibiotic growth promoters across various ASEAN nations, producers have increasingly adopted microbiome-support products to preserve gut integrity and enhance feed efficiency. Research has consistently shown that probiotic supplementation can optimize feed conversion performance and bolster disease resistance in high-density poultry, swine, and aquaculture production systems. As veterinarians and producers increasingly acknowledge the intrinsic link between gut health and overall animal performance, digestive health supplements are projected to remain the fastest-growing product category.

Competitive Landscape

The Southeast Asia veterinary nutraceuticals market is moderately fragmented, with competition driven by a combination of global animal health companies, pet nutrition manufacturers, animal nutrition specialists, and regional livestock health providers. Market participants compete based on product efficacy, scientific validation, veterinary recommendations, distribution networks, brand recognition, and the ability to address the diverse needs of both companion animals and livestock species across the region. Growing awareness of preventive animal healthcare, increasing pet ownership, and rising demand for antibiotic alternatives in livestock production continue to attract investments from both multinational and regional players.

Key companies operating in the Southeast Asia veterinary nutraceuticals market include Zoetis Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Virbac S.A., Ceva Santé Animale, Dechra Pharmaceuticals PLC, Vetoquinol S.A., Merck Animal Health (MSD Animal Health), Hill's Pet Nutrition, Inc. (Colgate-Palmolive Company), Mars, Incorporated (Royal Canin), Nestlé Purina PetCare Company, Phibro Animal Health Corporation, Betagro Public Company Limited, Kemin Industries, Inc., Alltech, Inc., and DSM-Firmenich. These companies compete through product innovation, veterinary engagement programs, companion animal wellness portfolios, livestock nutrition expertise, regional distribution capabilities, and investments in probiotics, prebiotics, functional feed additives, immune-support products, and microbiome-based health solutions.